Skip to main content

Find Clinical Trials

Home
Conditions
Filoviridae Infections

Clinical trial condition

Filoviridae Infections

Explore clinical trials studying Filoviridae Infections. Study availability and eligibility vary by location and protocol.

82 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Filoviridae Infections trial results

Completed

Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults

NCT02231866

Conditions: Filoviridae Infections, Healthy Adult Immune Responses to Vaccine, Hemorrhagic Fever, Ebola, +5 more
Locations: Hope Clinic - Emory Vaccine Ctr Decatur, Georgia, United States

University of Maryland Center for Vaccine Development Baltimore, Maryland, United States

National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study

NCT00646152

Conditions: DNA Virus Infections, Ebola, Filoviridae Infections, +18 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Study to Assess Ebola Vaccines ChAd3-EBO-Z and Ad26.ZEBOV

NCT02495246

Conditions: Ebola Virus Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford Oxford, Oxfordshire, United Kingdom

View Trial Details

Completed

STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)

NCT02378753

Conditions: Filoviridae Infections, Hemorrhagic Fever, Ebola, Hemorrhagic Fevers, Viral, +4 more
Locations: College of Medicine and Allied Health Sciences (COMAHS) Freetown, Western Area Urban, Sierra Leone

Bombali Bombali District, Sierra Leone

Port Loko Port Loko District, Sierra Leone

Tonkolili Tonkolili District, Sierra Leone

View Trial Details

Completed

Open Study of the Duration of Immunity After Vaccination With GamEvac

NCT02911428

Conditions: Filoviridae Infections, Hemorrhagic Fever, Ebola, Hemorrhagic Fevers, Viral, +4 more
Locations: Federal state budget military educational institution of higher education "Military medical Academy named after S. M. Kirov" Ministry of defense of the Russian Federation Saint Petersburg, Russia

View Trial Details

Completed

Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi

NCT02911415

Conditions: Ebola Hemorrhagic Fever, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Federal state budget military educational institution of higher education "Military medical Academy named after S. M. Kirov" Ministry of defense of the Russian Federation Saint Petersburg, Russia

View Trial Details

Completed

Ebola and Marburg Virus Vaccines

NCT00605514

Conditions: Animal Diseases, Ebola Vaccines, Ebola Virus Disease, +12 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Experimental Vaccine for Prevention of Ebola Virus Infection

NCT00374309

Conditions: Ebola Hemorrhagic Fever, Ebola Virus Disease, Ebola Virus Vaccines, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)

NCT02283099

Conditions: Filoviridae Infections, Hemorrhagic Fever, Ebola, Hemorrhagic Fevers, Viral, +4 more
Locations: CTC North GmbH & Co. KG Hamburg, Germany

View Trial Details

Completed

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

NCT02718469

Conditions: Ebola Virus Disease, Filoviridae Infections, Hemorrhagic Fever, Ebola, +5 more
Locations: Optimal Research Melbourne, Florida, United States

View Trial Details